Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

News at the Oxford-GSK Institute of Molecular and Computational Medicine

Our First Oxford-GSK Fellow

We are delighted to welcome Steph Fowler - Our first Oxford-GSK IMCM Fellow and funded for five years. Steph has a background in fish physiology and originally trained as a molecular neuroscientist in Ottawa, Canada.

Our Team

Talented scientists from across the world have joined our team. We have been honoured by the quality of applicants keen to join us as the institute. By the end of Q3 2023 we will have filled all of our posts. Not only are we bringing in new talent, we are also collaborating with with highly experienced colleagues from across GSK and Oxford University.

Progress in 2023 - putting data to work for patients

Everything we do is to enable the delivery of targeted successful treatments to patients. Initially our focus is on diseases driven by neuro-immunological mechanisms including Alzheimer’s, Parkinson’s, and Amyotrophic Lateral Sclerosis (ALS).